Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 55

Results For "Department"

648 News Found

Alloy Therapeutics acquires deepCDR Biologics to bring ML into drug discovery
Digitisation | December 17, 2021

Alloy Therapeutics acquires deepCDR Biologics to bring ML into drug discovery

The deepCDR engine combines deep sequencing and deep learning methods with a proprietary mammalian display process to select from a wide range of antibodies and rapidly identify candidates with the highest possible affinity and developability profiles


Baxter acquires Hillrom for US $ 15 billion
News | December 14, 2021

Baxter acquires Hillrom for US $ 15 billion

It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home


Govt. to organise Innovation Week to encourage startup ecosystem
Startup | December 13, 2021

Govt. to organise Innovation Week to encourage startup ecosystem

The proposed week-long event will comprise specific themes - International engagements, market access and incubation support, funding support to startups etc. and will cover the different areas of the innovation lifecycle


Alembic acquires stake in RIGlmmune
Biotech | December 11, 2021

Alembic acquires stake in RIGlmmune

The company is focused on the development of novel treatments for RNA viruses


Indian government approves eight firms for PLI scheme
Medical Device | December 10, 2021

Indian government approves eight firms for PLI scheme

The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore


Govt includes seven more companies under PLI scheme
News | December 10, 2021

Govt includes seven more companies under PLI scheme

Approvals accorded under Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ drug intermediates and Active Pharmaceutical Ingredients (APIs


Zydus receives  USFDA  approval for Phase2(b)/3 trial of Saroglitazar
Biotech | December 10, 2021

Zydus receives USFDA approval for Phase2(b)/3 trial of Saroglitazar

Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)


NMPB and CSIR-CIMAP sign MoU for joint collaboration
Policy | December 08, 2021

NMPB and CSIR-CIMAP sign MoU for joint collaboration

Working under the Ministry of Ayush, NMPB is mandated to coordinate all matters relating to medicinal plants and support policies and programs for growth of trade, export, conservation, and cultivation of medicinal plants


Over one lakh SARS-CoV-2 genomes sequenced till November
Policy | December 03, 2021

Over one lakh SARS-CoV-2 genomes sequenced till November

Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry


Fifty-five manufacturers selected for Pharma PLI sector
News | November 27, 2021

Fifty-five manufacturers selected for Pharma PLI sector

The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme